Sun Pharma.Inds. Reports Flat Performance in Q1, Highest PAT and EPS in 5 Quarters

May 22 2024 06:00 PM IST
share
Share Via
Sun Pharmaceuticals Industries has announced its financial results for the quarter ended March 2024, with a flat performance and a 'Hold' call from MarketsMojo. The company's PAT and EPS were the highest in the last five quarters, indicating a positive trend in profitability. However, PBT and Non Operating Income have shown a negative trend, raising concerns for the company's future performance.

Sun Pharmaceuticals Industries, a largecap pharmaceutical company, has recently announced its financial results for the quarter ended March 2024. The company's stock has been given a 'Hold' call by MarketsMOJO.

According to the financial report, Sun Pharma.Inds. has shown a flat performance in the quarter, with a score of 4 out of 8, which is a decrease from the previous score of 8 in the last 3 months.

On the positive side, the company's Profit After Tax (PAT) for the quarter was the highest at Rs 2,750.84 crore and has been growing consistently in the last five quarters. This indicates a very positive trend in the near term for the company's profitability. Additionally, the company's Earnings per Share (EPS) for the quarter was also the highest at Rs 11.06, showing an increase in profitability and creating higher earnings for shareholders.

However, there are some areas of concern for Sun Pharma.Inds. as well. The Profit Before Tax less Other Income (PBT) for the quarter was at Rs 2,311.22 crore, which is a decrease of -7.1% from the average PBT of the previous four quarters. This indicates a negative trend in the near term for the company's PBT. Moreover, the Non Operating Income for the quarter was at its highest at Rs 605.94 crore, which may not be sustainable as it comes from non-business activities.

Overall, Sun Pharmaceuticals Industries has shown a mixed performance in the quarter ended March 2024. Investors are advised to hold their positions in the company's stock, as recommended by MarketsMOJO.
{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News